Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12620000914965
ACTRN12620000914965
Recruiting
Phase 3

The C*STEROID Trial. Antenatal corticosteroids prior to planned caesarean section delivery from 35+0 to 39+6 weeks gestation; a randomised controlled trial assessing the effects on neonatal respiratory morbidity and glycaemic control.

The University of Auckland0 sites2,548 target enrollmentSeptember 16, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCaesarean section deliveryRespiratory distress syndromeTransient tachypnoea of the newbornNeonatal hypoglycaemiaRespiratory - Other respiratory disorders / diseasesReproductive Health and Childbirth - Complications of newborn

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Caesarean section delivery
Sponsor
The University of Auckland
Enrollment
2548
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 16, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Women for whom caesarean section is planned pre\-labour at 35\+0 to 39\+6 weeks gestation.
  • •2\. \>24 hours and \<7 days before planned birth.
  • •3\. Singleton or twin pregnancy with a live fetus.

Exclusion Criteria

  • •1\. Diabetes: pre\-existing or gestational.
  • •2\. Major fetal abnormality.
  • •3\. Prior corticosteroid use in this pregnancy (intramuscular corticosteroid use for fetal lung maturity).
  • •4\. Prior enrolment in the C\*STEROID Feasibility Study or C\*STEROID Trial, in a previous pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The role of steroids in infection-related glomerulonephritis
ISRCTN13723530Madras Medical College86
Completed
Not Applicable
MACS: Multiple Courses of Antenatal Corticosteroids for Preterm Birth StudyPregnancies at increased risk of preterm birthPregnancy and ChildbirthPreterm birth
ISRCTN72654148niversity of Toronto Faculty of Medicine Research Office (Canada)1,900
Completed
Not Applicable
Corticosteroid in brucellosisBrucellosis.Brucellosis, unspecified
IRCT201106296922N1Zanjan University of Medical Sciences47
Not yet recruiting
Phase 2
A pilot study of corticosteroid and antihistamine premedication to prevent hypersensitivity reactions in patients receiving second (or subsequent) line treatment with Carboplatin for treatment of gynaecological malignancyhypersensitivity reactions in patients receiving carboplatin for gynaecological malignancyCancer - Ovarian and primary peritonealCancer - Womb (Uterine or endometrial cancer)
ACTRN12613000646741The Royal Women's Hospital46
Completed
Not Applicable
The impact of including corticosteroid in a periarticular injection for pain control after total hip arthroplasty: a double blind randomized controlled trialOsteoarthritis of the hip, rheumatoid arthritis, avascular necrosis of the femoral head, femoral neck fracture
JPRN-UMIN000033059Hokusuikai Kinen Hospital120